18th Annual Mark E. Nesbit Lectureship in Pediatric Oncology
Gregory H. Reaman, M.D.
Professor of Pediatrics, The George Washington University School of Medicine and Health Sciences;
Chair, Children's Oncology Group, Bethesda, MD
May 20, 2009
Teaching Objectives:
1.Participants should understand that there is broad clinical and biologic heterogeneity in childhood ALL
2.Participants should understand that ALL in children is highly curable resulting from decades of collaborative clinical research and that, despite the extraordinary progress; ALL remains the second highest cause of cancer-related mortality
3.Participants should understand that further collaborative investigations, including genomic investigations have the
potential to further treatment advances